F.D.A. Rejects InterMune’s Drug for Fatal Lung Disease
Wednesday, May 5, 2010 - 00:21
in Health & Medicine
The company said the F.D.A. had requested another clinical trial to prove that the drug was effective against idiopathic pulmonary fibrosis.